WATER INDUSTRY FEATURES, INSIGHTS, AND ANALYSIS
-
The Enzyme Bottleneck: Why Conventional Lake Management Is Failing — And What The Science Says About Genuine Bio-Dredging
For decades, the dominant framework for assessing and managing lake health has been built around surface water measurements: chlorophyll-a, total phosphorus, water clarity, and the composite Trophic State Index derived from them. These metrics are familiar, standardised, and widely accepted. They are also, according to a growing body of peer-reviewed literature, measuring the wrong part of the lake.
-
Ozone Off-Gas: What It Reveals About System Efficiency, Safety, and Design
Learn how ozone off-gas impacts system efficiency, safety, and performance, and why monitoring and management are critical for optimized water treatment operations.
-
UK Reservoirs, Water Shortages, And Legionella Risks
Is there a clear link between a less plentiful water supply and an increase in Legionella in our domestic water systems?
-
The Devastating Legacy Of Algaecides: Why The Quick Fix Is Failing Our Lakes As warmer months approach, water management professionals must confront the compounding consequences of biocidal algae treatments.
-
What Is The Future Of Source Water Protection? Water utility managers and municipal leaders have long struggled amid the convergence of several threats to public water supplies. During a recent Water Online Live event, I sat with a panel of industry experts to examine the transition from reactive crisis management to a proactive, adaptive resilience framework.
-
Drinking Water Contaminated With 'Forever Chemicals' During Pregnancy Linked To An Increased Risk Of Childhood Asthma
While most of us are routinely exposed to low levels of PFAS, some communities are exposed to far higher levels from nearby pollution sources. A new study shows that in one of these at-risk communities, children were more likely to develop asthma if their mothers were exposed to very high PFAS levels during pregnancy.
-
The Pragmatic Shift In Source Water Protection: Moving From Symptom Management To Root-Cause Accountability A shift in how we approach source water protection is long overdue. Currently, we are trapped in a cycle of escalating costs, forced to treat symptoms like algae and invasive weeds expediently with chemicals while the underlying risk in the reservoir compounds. True risk management requires breaking this cycle.
-
The AWWA Said $2.4 Trillion. It Missed The Compound Interest. Einstein once said of compound interest, "He who understands it, earns it. He who doesn't, pays it." The same logic of compounding applies to the organic sediment accumulating on the floor of your drinking water reservoir. The longer you wait to address it, the more exponentially expensive it becomes to fix.
-
Designing Resilient PFAS Treatment Strategies For Water Agencies Water agencies across the U.S. are facing a rapidly evolving regulatory landscape for per- and polyfluoroalkyl substances (PFAS) that poses a conundrum: Should they take a cautious or aggressive approach to treating PFAS contamination in their water system?
-
The Future Of In Situ Chemical Oxidation For Targeted Solvent Destruction
The U.S. EPA’s 2026 trichloroethylene (TCE) compliance deadlines are now forcing a concrete shift toward source-zone destruction. In situ chemical oxidation (ISCO), sequenced with enhanced bioremediation, is proving to be the most credible path to groundwater contaminant rebound mitigation.
VIEWS ON THE LATEST REGS
-
Despite renewed public concern over fluoride and cognition, the National Toxicology Program’s findings focus on high‑fluoride groundwater conditions — not the controlled levels used in U.S. drinking water systems. Understanding that distinction is critical for utilities navigating policy questions and community expectations.
-
In this Q&A, Dr. Elke Süss of Metrohm addresses the urgent need for haloacetic acid testing in response to “one of the most significant updates to EU drinking water monitoring in recent years.”
-
With the U.S. EPA's PFAS rules now in place, utilities are finding themselves with a growing number of questions regarding how to treat these chemicals, the potential costs, and much more. For answers, Water Online's chief editor, Kevin Westerling, hosted an Ask Me Anything session featuring Ken Sansone, Senior Partner at SL Environmental Law Group; Kyle Thompson, National PFAS Lead at Carollo Engineers; and Lauren Weinrich, Principal Scientist at American Water.
-
A Q&A to explain and resolve issues confronting water suppliers as they endeavor to comply with the monitoring requirements of federal PFAS regulations.
-
Assessing what lies ahead in the 10-year race to go lead-free, otherwise known as the Lead and Copper Rule Improvements (LCRI).
MORE WATER INDUSTRY FEATURES
-
Explore how PFAS in medical devices pose environmental and health concerns, prompting regulatory scrutiny.
-
This article will clarify the essential aspects of turbidity, how it can affect human health, and how best to measure and mitigate it.
-
Continuous water quality monitoring helps utilities offset workforce shortages, reclaim thousands of labor hours, improve compliance, and gain real-time insights that enhance system performance and reliability.
-
Founded in 1982, Peace River Manasota Regional Water Supply Authority supplies drinking water to a region of approximately one million people. Its surface water treatment plant draws water from the Peace River to a reservoir and treats it to drinking water standards at the rate of about 31 million gallons a day.
-
What separates genuine exosomes from microvesicles, apoptotic bodies, or lipoproteins? Explore the markers, assays, and biogenesis pathways that define these particles beyond popular terminology.
-
From droughts to floods to leaking pipes, water utilities are under more pressure than ever. Traditional infrastructure wasn’t designed for today’s demands, but digital technology is helping close the gap. Tucson Water, Buffalo Sewer Authority and Hot Springs are three utilities leveraging Xylem’s intelligent solutions to identify and address issues before they happen – providing a cleaner, more reliable water supply for the communities they serve.
-
In this article, Transcend will break down the evolution and impact of PFAS regulations over the years while suggesting innovative technology to assist the affected industries.
-
NMR reveals far more than structure, offering insights into purity and molecular behavior. Advanced analysis unlocks deeper value from data to better understand mixtures and 3D structures.
-
Nitrosamines are a serious risk in drug products, driven by the presence of secondary amines, conducive conditions, and nitrosating agents. Understanding these factors is key to risk mitigation and patient safety.
-
Discover how new processing methods tackle challenges in large-scale stem cell production and how automated, low-shear processing maintains cell health and pluripotency across production scales.
-
CMMS and EAM go-lives in GMP environments hinge on more than timing. Explore how big-bang, phased, compliance-first, and patchwork approaches shift validation effort, audit risk, and operational strain.
-
Thermal reactivation of granular activated carbon is a proven and scalable method to achieve >99.9% destruction removal efficiency for PFAS. This process fully restores the carbon for reuse, providing a sustainable solution that breaks the cycle of "forever chemicals."
-
In response to insufficient traditional dose-escalation methods, regulatory initiatives like the FDA’s Project Optimus advocate for identifying optimal biological doses rather than relying solely on maximum tolerated doses (MTD).
-
Learn about a novel solution dramatically improving the purification and yield of promising nanoscale vesicles for medical applications.
-
Emerging state water reuse regulations are driving adoption of ozone and advanced oxidation, requiring flexible, high-performance systems to meet pathogen, trace organic, and DBP control objectives.
-
Precision medicine is opening new possibilities for IMIDs by moving beyond symptom‑based care. Find out how emerging multi‑omics tools are reshaping how these complex diseases are understood.
-
Explore how Fc engineering transforms antibodies into precise therapeutic tools by modulating immune effector functions and extending half-life to improve patient outcomes and overcome complex clinical challenges.
-
Breakthrough Therapy designation (BTD) can accelerate rare disease drug development—but timing and evidence are everything. Learn how to position your program for FDA success.